Press releases

9
May 2017
20:30 E.S.T.

Cellectis Reports 1st Quarter 2017 Financial Results

Read more
27
Apr 2017
20:30 E.S.T.

Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference

Read more
25
Apr 2017
20:30 E.S.T.

Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting

Read more
12
Apr 2017
20:30 E.S.T.

Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.

Read more
31
Mar 2017
20:30 E.S.T.

Cellectis to Present at the 2017 Annual Conference of the American Association for Cancer Research

Read more
9
Mar 2017
21:30 E.S.T.

Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

Read more
7
Mar 2017
21:30 E.S.T.

Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

Read more
6
Mar 2017
21:30 E.S.T.

Cellectis Reports 4th Quarter and Full Year 2016 Financial Results

Read more
7
Feb 2017
21:30 E.S.T.

Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

Read more
6
Feb 2017
21:30 E.S.T.

FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123, the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U.S.

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US